Back
ConocoPhillips 10K Form
Sell
47
COP
ConocoPhillips
Last Price:
101.91
Seasonality Move:
0.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-03 | 10Q | COP/ConocoPhillips Quarterly |
2020-08-04 | 10Q | COP/ConocoPhillips Quarterly |
2020-05-05 | 10Q | COP/ConocoPhillips Quarterly |
2020-02-18 | 10K | COP/ConocoPhillips Annual |
2019-10-31 | 10Q | COP/ConocoPhillips Quarterly |
2019-08-01 | 10Q | COP/ConocoPhillips Quarterly |
Receive COP News And Ratings
See the #1 stock for the next 7 days that we like better than COP
COP Financial Statistics
Sales & Book Value
Annual Sales: | $78.49B |
---|---|
Cash Flow: | $2.51B |
Price / Cash Flow: | 6.86 |
Annual Sales: | $39.49 |
Price / Book: | 2.59 |
Profitability
EPS (TTM): | 12.50000 |
---|---|
Net Income (TTM): | $15.84B |
Gross Margin: | $30.01B |
Return on Equity: | 32.42% |
Return on Assets: | 16.96% |
ConocoPhillips Earnings Forecast
Key ConocoPhillips Financial Ratios
- The Gross Profit Margin over the past 39 years for COP is 38.24%.
- The Selling, General & Administrative Expenses for COP have been equal to 0.79% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 5.65% of Operating Income.
- The Net Earning history of COP is 23.80% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 21 years.
ConocoPhillips Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Oil & Gas E&P |
Sector: | Energy |
Current Symbol: | COP |
CUSIP: | 20825C |
Website: | conocophillips.com |
Debt
Debt-to-Equity Ratio: | 0.35 |
---|---|
Current Ratio: | 1.4 |
Quick Ratio: | 1.2 |
Price-to-Earnings
Trailing P/E Ratio: | 7.02 |
---|---|
Forward P/E Ratio: | 10.01 |
COP Technical Analysis vs Fundamental Analysis
Sell
47
ConocoPhillips (COP)
is a Sell
Is ConocoPhillips a Buy or a Sell?
-
ConocoPhillips stock is rated a Sell
The current ConocoPhillips [COP] share price is $102.35. The Score for COP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.